v3.25.0.1
REVENUE (Tables)
 12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of revenue by segment by geographic area Revenue by segment and geography based on shipped to locations for the years ended December 31, 2024, 2023 and 2022 were as follows:
For the Year Ended December 31, 2024
SegmentEuropeDomesticLatin
America		AsiaTotal
Aptar Pharma$806,606 $556,642 $47,124 $232,780 $1,643,152 
Aptar Beauty745,198 241,115 155,692 83,725 1,225,730 
Aptar Closures218,064 347,733 83,376 64,835 714,008 
Total$1,769,868 $1,145,490 $286,192 $381,340 $3,582,890 
For the Year Ended December 31, 2023
SegmentEuropeDomesticLatin
America		AsiaTotal
Aptar Pharma$779,929 $495,057 $52,074 $193,933 $1,520,993 
Aptar Beauty806,963 219,760 152,963 88,011 1,267,697 
Aptar Closures218,833 336,315 84,146 59,466 698,760 
Total$1,805,725 $1,051,132 $289,183 $341,410 $3,487,450 
For the Year Ended December 31, 2022
SegmentEuropeDomesticLatin
America		AsiaTotal
Aptar Pharma$683,217 $446,821 $38,483 $192,735 $1,361,256 
Aptar Beauty715,797 280,023 134,883 91,832 1,222,535 
Aptar Closures217,162 378,503 79,482 63,311 738,458 
Total$1,616,176 $1,105,347 $252,848 $347,878 $3,322,249 
Schedule of opening and closing balances of contract assets and contract liabilities
The opening and closing balances of our contract asset and contract liabilities are as follows:
Balance as of December 31, 2023Balance as of December 31, 2024Increase/
(Decrease)
Contract asset (current)$18,033 $12,571 $(5,462)
Contract liability (current)60,507 64,425 3,918 
Contract liability (long-term)37,756 40,551 2,795